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The proneural basic helix-loop-helix (bHLH) proteins promote neurogenesis by inducing changes in gene expression required for
neuronal differentiation. Here we characterize one aspect of this differentiation program by analyzing a small family of putative corepressors
encoded by MTG genes. We show that MTG genes are expressed sequentially during neurogenesis as cells undergo neuronal differentiation
in both the chick spinal cord and in the Xenopus primary nervous system. Using in ovo electroporation, we show that misexpressing wild-
type forms of MTG proteins in the developing chick spinal cord does not detectably alter neuronal differentiation. By contrast, the number of
differentiated neurons is markedly reduced when a putative dominant-negative mutant of the MTG proteins is expressed in neural precursors
in a manner that can be rescued by wild-type MTGR1. Together, these results suggest that MTG family members act downstream of
proneural proteins, presumably as corepressors, to promote neuronal differentiation.
D 2004 Elsevier Inc. All rights reserved.
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A cascade of gene expression activated by proneural
basic helix-loop-helix (bHLH) proteins plays an essential
and conserved role in promoting neuronal differentiation
during the process of neurogenesis (for review, see Bertrand
et al., 2002). The nature of this gene cascade has been
studied extensively during primary neurogenesis in Xenopus
embryos by exploiting the ability of proneural bHLH
proteins to promote neuronal differentiation when ectopi-
cally expressed. For example, when the proneural bHLH
protein Xngn1 is misexpressed in early embryos, it activates
a panel of downstream target genes that are associated with
the progression of neural precursors into differentiated
neurons, resulting in ectopic neuronal differentiation (Ma
et al., 1996). These targets include genes encoding
components of the Notch signaling pathway, which medi-
ates the process of lateral inhibition (Koyano-Nakagawa et0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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proneural bHLH genes such as Xath3 and XNeuroD, which
act to promote terminal neuronal differentiation. Finally,
Xngn1 activates a panel of genes encoding other tran-
scription factors, such as Olf-1/Xcoe2, MyT1, NKL, and
Hes6 (Bae et al., 2000; Bellefroid et al., 1996; Dubois et al.,
1998; Koyano-Nakagawa et al., 2000; Lamar et al., 2001;
Pozzoli et al., 2001). Some of these transcription factors
appear to regulate the efficacy of bHLH transcription factors
and thus whether a neural precursor differentiates. Other
targets may activate or repress genes that function in the
physiological changes associated with neuronal differentia-
tion, including cell cycle exit, cell growth, and alterations in
cell morphology. Proneural proteins therefore induce neuro-
nal differentiation by activating the expression of a large
number of transcription factors, but how these factors
control the progression of precursors into neurons remains
poorly understood.
To further dissect the genetic changes that occur during
neuronal differentiation, we have used differential screening
and identified additional transcriptional targets of Xngn1.278 (2005) 22–34
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Xngn1 in this screen encodes a Xenopus homolog of
MTGR1, previously reported as XETOR (Cao et al., 2002).
MTGR1 belongs to a small family of related proteins that
were originally identified at chromosomal translocation
points and deletions associated with naturally occurring
and treatment-induced acute myeloid leukemia (for reviews,
see Davis and Turner, 2001; Lutterbach and Hiebert, 2000).
The MTG family contains at least three members in human
and mouse, namely, MTG8 (also called CBFA2T1, CDR,
and ETO), MTG16 (also called CBFA2T3, MTGR2, and
ETO2), and MTGR1 (also called ETOR1 and EHT). MTG
proteins are highly conserved during evolution and include a
fly homolog called nervy based on its high level of
expression in all neuroblasts presumably in response to
proneural proteins (Feinstein et al., 1995). By sequence
comparison, MTG proteins contain several signature motifs,
including highly conserved domains termed nervy homol-
ogy regions (NHRs) (Davis et al., 2003 and Fig. 1). A
number of studies using biochemical and molecular
approaches mainly using MTG8/ETO suggest that these
proteins are nuclear and act as transcriptional corepressors
by dimerizing and bridging interactions among multiple
proteins, including proteins with histone deacetylase activity
(Amann et al., 2001; Gelmetti et al., 1998; Lutterbach et al.,
1998; Wang et al., 1998; Zhang et al., 2001). These findings
suggest that MTG proteins regulate transcription when
recruited to specific sites by DNA binding proteins such as
the promyelocytic leukemia zinc finger protein (PLZF)
(Melnick et al., 2000), the Dentato-rubral and Pallido-lusian
atrophy (DRPLA) gene product, atrophin-1 (Wood et al.,
1999, 2000), growth factor independence-1 (Gfi-1)Fig. 1. Alignment of MTG proteins. (A) Amino acid identities of chick, Xenopus, m
sequence. Numbers on the right show amino acid (a.a.) lengths. (B) Phylogeneti
MTG16b are splice variants.(McGhee et al., 2002, 2003), and B-cell lymphoma 6
(BCL-6) (Chevallier et al., 2004).
Despite extensive efforts to understand the function of
MTG proteins in the etiology of cancer, relatively less is
known about their function in normal embryonic develop-
ment. Inactivation of MTG8/ETO by insertional mutation
results in mice exhibiting a gut phenotype but no gross
defect in nervous system development (Calabi et al., 2001).
In Drosophila, the MTG homolog nervy has been recently
shown to function during axon guidance as an A kinase
anchoring protein (AKAP) to plexinA (Terman and Kolod-
kin, 2004). Whether the vertebrate nervy counterparts share
this novel cytoplasmic function has yet to be determined.
Functional analysis of Xenopus MTGR1/XETOR in frog
embryos suggests that it inhibits neurogenesis by expanding
the neural plate as well as by interfering with proneural
bHLH function (Cao et al., 2002). In general, however, the
role of the MTG protein family in vertebrate neural
development is largely unexplored.
Here we examine the function of MTG proteins during
neurogenesis further by isolating and characterizing Xen-
opus and chick cDNAs that encode members of the MTG
family including XMTG8, XMTG16, cMTG8, cMTG16,
and cMTGR1. We show that the chick MTG proteins are
expressed sequentially when postmitotic neurons differ-
entiate in the developing chick spinal cord and that Xngn1
can induce a similar sequence of MTG gene expression
during primary neurogenesis in Xenopus. In addition,
inhibiting the function of these proteins in the developing
chick spinal cord results in a reduction in the number of
cells that undergo neuronal differentiation. These results
indicate that MTG proteins, presumably acting as transcrip-ouse, and human MTGR1 within NHR 1–4 are shown relative to the chick
c tree of human, Xenopus, and chick MTG family proteins. MTG16a and
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when they transit into terminally differentiated neurons.Materials and methods
Egg laying and in vitro fertilization of Xenopus laevis
Embryos were obtained from X. laevis adult frogs by
hormone-induced egg-laying and in vitro fertilization using
standard methods (Sive et al., 2000). Xenopus embryos
were staged according to Nieuwkoop and Faber (1967).
Plasmids
For RNA synthesis, cDNAs were subcloned into the
pCS2(+) MT vector (D. Turner, CS2 vector resource,
website: sitemaker.umich.edu/dlturner.vectors), linearized
with NotI, and transcribed with SP6 polymerase (Sive et
al., 2000). For in ovo electroporation, cDNAs were
subcloned into the pMiwSV vector (Funahashi et al.,
1999). For the generation of in situ hybridization probes,
cDNAs were subcloned in pBSII (Stratagene) and prepared
as templates as described further below. Expression
constructs of MTG proteins were constructed by PCR
amplifying the coding regions, engineering NcoI and XhoI
sites at the 5’ and 3’ ends, respectively, and subcloning into
the NcoI–XhoI fragment of the pCS2(+) MT vector.
Expression construct of XMTGR1-MR, pCS2(+)MT-
XMTGR1-MR, was created by serial digestion, blunting,
and religation of pCS2(+)MT-XMTGR1 with combination
of two enzymes, NcoI and PflM1, and BglII and XhoI,
respectively. This plasmid produces a peptide with amino
acids 193–427 of XMTGR1 protein linked to the myc
epitope.
RNA injection and embryo manipulation
Synthetic mRNAs (300–500 pg) along with 250 pg of
mRNA encoding a tracer gene nLacZ were injected into
Xenopus embryos into the animal pole of one blastomere at
the two-cell stage. Embryos were collected at appropriate
stages, fixed, and stained for h-galactosidase activity
according to standard protocols (Sive et al., 2000) prior to
analysis using whole mount in situ hybridization. For
experiments using animal caps, 1 ng of RNA was injected
into both blastomeres at stage 2, allowed to develop to stage
9, when animal caps were removed, and cultured in 0.5
MMR containing 50 Ag/ml gentamycin until sibling controls
reached the appropriate stage.
RNA isolation and generation of hybridization probes
RNA from 700 animal cap explants was isolated using
TRI reagent (Molecular Research Center, Inc.) and further
purified by Lithium precipitation. Messenger RNA wasisolated using PolyA tract system (Promega). Labeled
probes for filter hybridization were generated with
random primers and Klenow polymerase using reverse-
transcribed mRNA as a template (Sambrook and Russell,
2001).
Isolation of Xenopus and chick MTG family genes
A Xenopus EZAP cDNA library (Stratagene) was
constructed using RNA extracted from animal caps
injected with RNAs encoding noggin and Xngn1 and
harvested at time equivalent to stage 16 (Koyano-
Nakagawa et al., 1999). The unamplified library was
plated at 800 pfu/150 mm plate and incubated until
diameter of plaques reached ~1 mm. Four replica filters
were lifted from each plate and hybridized with probes
synthesized from cDNAs derived from uninjected animal
caps, caps injected with either noggin RNA alone or
combination of noggin and Xngn1 RNA, or with probes of
known genes. Prior to probe synthesis, each cDNA was
enriched by subtractive hybridization with biotinylated
RNAs from stage 9 embryos (Herfort and Garber, 1991;
Sive and St John, 1988). Clones that hybridized preferen-
tially to Xngn1-injected animal cap probe were isolated
and sequenced. Chick and other Xenopus MTG homologs
were isolated by low-stringency hybridization using stand-
ard techniques (Sambrook and Russell, 2001). The
sequences are deposited in GenBank under the following
accession numbers: XMTG8; AY714077, XMTG16;
AY14078 and AY14079, XMTGR1; AY14080, cMTG8;
AY14073, cMTG16; AY14074 and AY14075, cMTGR1;
AY14076.
In situ hybridizations
Whole-mount in situ hybridizations were performed
according to standard protocols (Sive et al., 2000) using
probes that were linearized by restriction enzyme digest and
transcribed with T3 or T7 RNA polymerase as follows: Elr-
C and XMTG8 (EcoR1, T7), XMTG16 and XMTGR1 (Pst
I, T7), cMTG8, cMTG16, and cMTGR1 (Not1, T7), and
Xath3 (EcoRI, T3). Probes for N-tubulin, XNeuroD,
XMyT1 have been described previously (Bellefroid et al.,
1996; Lee et al., 1995; Ma et al., 1996). Following in situ
hybridization, chick embryos were embedded in agarose and
sectioned to 70-Am thickness using a vibratome.
Immunohistochemistry
Chick embryos were fixed in 4% paraformaldehyde/1
PBS, equilibrated in 25% sucrose/1PBS, and embedded in
O.C.T. compound (Tissue-Tek). Embryos were sectioned on
a cryostat at 15 Am, mounted onto slides, and stained
according to the standard protocol. For anti-BrdU staining,
sections were fixed in 4% paraformaldehyde for 10 min and
treated with 2 N HCl for 30 min prior to immunostaining.
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Issay Kitabayashi (National Cancer Center Research Insti-
tute, Japan) (Kitabayashi et al., 1998). Prox1 antibody was
obtained from Masato Nakafuku (Cincinnati Children’s
Hospital Medical Center) (Torii et al., 1999). Antibody
against cNgn2 was from David Anderson (Zhou et al.,
2001). Antibodies were used at the following concentra-
tions: BrdU (MAS250, Harlan), 1:500; Pax2 (Zymed),
1:200; Lim 1/2 (4F2, Developmental Studies Hybridoma
Bank: DSHB) (Ericson et al., 1996), 1:1000; Isl-1 (40.2D6,
DSHB) (Ericson et al., 1992), 1:1000; myc mouse mono-
clonal (9E10, DSHB) (Evan et al., 1985), 1:20; myc rabbit
polyclonal (MBL), 1:500; MTGR1, 1:5000; Prox1, 1:1000;
Ngn2, 1:5000.
Chick in ovo electroporation
In ovo electroporation was performed as previously
described (Funahashi et al., 1999). Electrodes were 0.5-mm
diameter, 4-mm length, and held at a 4-mm distance. Five
rectangular pulses of 25 V, 50-ms duration time were
applied at 1 Hz. Embryos were electroporated at Ham-
burger–Hamilton stage 13 and harvested at stage 22. For
BrdU incorporation assays, 0.1–0.5 Al of BrdU solution (50
mg/ml dissolved in 0.9% (w/v) NaCl) was injected into the
spinal cord at the indicated time prior to harvest.Results
Isolation of MTG family genes
To identify genes activated by neural bHLH proteins
during neuronal differentiation, an enriched Xenopus cDNA
library was screened differentially using probes enriched by
subtractive hybridization as described in Materials and
methods. The most frequent clone identified in this screen
encodes a Xenopus homolog of MTGR1, previously
reported as XETOR1 (Cao et al., 2002). In human and
mouse, MTGR1 (also called ETOR1 and EHT) belongs to a
family containing two other closely related members,
namely MTG8 and MTG16. Accordingly, we used low
stringency hybridization to isolate cDNA clones encoding
MTG8 and MTG16 from frogs as well as three MTG family
members from chick. Aligning the three forms of MTG
proteins in chick and frog with those in mouse and human
illustrates the high level of conservation of these genes
among different vertebrate species, including forms of
proteins that correspond to splice variants (Fig. 1).
Particularly high levels of sequence homology are evident
within previously reported protein motifs, including Nervy
homology region (NHR) 1 (also called the TAF110
homology domain), NHR2, which overlaps with a dimeri-
zation domain, NHR3, and NHR4, a carboxy terminal zinc
finger-like domain involved in transcriptional repression
(Davis et al., 2003).Expression of MTG family members during neurogenesis
Expression of one MTG family member MTGR1 occurs
at an early stage of primary neurogenesis in Xenopus
embryos (Cao et al., 2002). To determine if other MTG
genes are also expressed during neurogenesis, we used
whole-mount in situ hybridization to examine the expres-
sion of cMTGR1, cMTG8, and cMTG16 in the developing
spinal cord of stage 22 chick embryos. The results show that
all three MTG genes are expressed during neurogenesis in
the chick spinal cord but with different patterns. cMTGR1 is
expressed in a narrow stripe of cells that extends along the
entire D–V axis of the spinal cord and is situated between
progenitor cells located in the ventricular zone (VZ) and the
differentiated neurons located in the mantle (Fig. 2A). This
pattern resembles that of a number of transcription factors
that are activated in a region called the intermediate zone
(IZ) as neural precursors leave the cell cycle and move
laterally to initiate neuronal differentiation (Roztocil et al.,
1997). By contrast, cMTG8 and cMTG16 are expressed in
the mantle zone (MZ) in the position of differentiated
neurons and are apparently excluded from the IZ where
cMTGR1 is primarily expressed (Figs. 2B and C). In
addition, cMTG8 and cMTG16 expression is restricted
along the D–V axis of the spinal cord to domains
corresponding to the position of postmitotic motorneurons
and interneurons, respectively. Thus, expression of MTG
genes in the chick spinal cord occurs both in the IZ and in
differentiated neurons that comprise the early MZ.
The finding that cMTG8 and cMTG16 are expressed in
differentiated neurons led us to ask whether these MTG
family members are also expressed during primary neuro-
genesis in Xenopus embryos. The results show that at early
neural plate stages when XMTGR1 is strongly expressed
broadly in the domains where primary neurons form (Fig.
2J), the expression of both XMTG8 and XMTG16 is weak
and detectable in a small number of cells (Figs. 2D and G).
As primary neurogenesis proceeds and the expression of
MTGR1 in the prospective spinal cord starts to decline,
expression of both XMTG8 and XMTG16 is upregulated in
what appears to be definitive primary neurons (Figs. 2E
and H). As noted above in the chick, the expression
domains of XMTG8 and XMTG16 within the developing
nervous system are more restricted than that of XMTGR1.
Whereas XMTGR1 seems to be expressed equally in most,
if not all, neuronal progenitors (Figs. 2J and K), XMTG8 is
strongly expressed in the trigeminal primordia and weakly
in the three stripes of primary neurons (Fig. 2D, arrow-
heads). XMTG16 is expressed mainly in the lateral stripes
and the trigeminal primordia, and weakly in the medial and
the intermediate stripes of the primary neurons (Figs. 2G
and H, arrowheads). Since the expression patterns of
XMTG8 and XMTG16 are associated with differentiated
primary neurons, we asked if their expression could be
induced ectopically by ectopic expression of Xngn1, as
reported for XMTGR1 (Cao et al., 2002). Indeed, Xngn1
Fig. 2. Expression of the MTG family of genes during neurogenesis. (A–C) Stage 22 chick embryos were stained for cMTGR1 (A), cMTG8 (B), and cMTG16
(C) RNA expression, and sectioned at branchial levels. Scale bar: 100 Am. (D–L) Xenopus embryos were stained in whole-mount with probes for XMTG8
(D–F and L), XMTG16 (G–I), and XMTGR1 (J and K) at the open neural plate stage (stage 14) or after neural tube closure (stage 17). Anterior end is oriented
to the left. White arrowheads point to trigeminal primordia. Black arrowheads indicate three stripes of prospective neurons: m, medial; i, intermediate; l,
lateral stripe. Note the widespread expression of XMTGR1 in all areas of primary neurogenesis at stage 14, while expression of XMTG8 and XMTG16 is more
prominent in primary neurons at late neurula stage. At stage 14, XMTG8 is expressed stronger in trigeminal primordia than the primary neurons, while
XMTG16 is predominantly seen in lateral stripe of primary neurons. In panels F and I, embryos were injected into one blastomere at stage 2 with mRNA
encoding Xngn1 along with a LacZ RNA tracer. At early neurulae stages, the injected embryos were processed for staining for h-galactosidase (dark magenta
nuclear stains) and in situ hybridization (purple cytoplasmic stain) using probes for MTG8 (F) and MTG16 (I). Shown is a lateral view of the embryo in a
region of the skin outside the nervous system. The boxed area in panel F is enlarged in panel L. Scale bars for D–L: 0.5 mm.
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outside the neural plate (Figs. 2F, I, and L). Together, these
results suggest that MTG genes are expressed sequentially
during the process of neuronal differentiation, most likely
as a downstream consequence of proneural protein activity.
Expression of MTGR1 occurs primarily in postmitotic
neuronal precursors
In both Xenopus and chick, expression ofMTGR1 during
neurogenesis occurs around the point where neural pre-
cursors leave the cell cycle and differentiate into neurons. To
determine the timing of this expression more precisely,
sections of stage 22 chick embryos were stained with
antibodies directed against cMTGR1 and to two other
transcription factors Pax6 and Lim1/2 whose expression
marks the progression of neural precursors into neurons.Pax6 (Figs. 3A and C) is strongly expressed in proliferating
VZ cells and downregulated in the MZ, while Lim 1/2 (Figs.
3E and G) is upregulated as neural precursors become
postmitotic and differentiate in the MZ (Tsuchida et al.,
1994). The results show that most of the cells expressing
MTGR1 lie outside the VZ where Pax6 is expressed
strongly and overlap with a lateral domain where Pax6 is
expressed weakly (Figs. 3B–D, brackets). A small popula-
tion of cells with weak MTGR1 immunoreactivity can be
detected in the VZ (Figs. 3B–D, arrows), but this population
also expresses Pax6 weakly, perhaps indicating that these
cells are in the process of migrating from the VZ to the IZ.
In addition, there is significant overlap between cells
expressing MTGR1 and those that express Lim1/2, although
more medially located MTGR1+ cells are Lim1/2 negative
(Figs. 3F–H, arrows) and the more lateral Lim1/2+ cells
located in the marginal zone are MTGR1 negative (Figs.
Fig. 3. Expression of cMTGR1 in postmitotic spinal neurons. (A–H) Sections of stage 22 chick embryos were double stained with anti-MTGR1 (red) and anti-
Pax6 (green) antibodies (A–D) or with anti-MTGR1 (red) and anti-Lim 1/2 (green) antibodies (E–H). Boxed area in panels A and E are enlarged in panels B–D
and F–H, respectively. Note that MTGR1 expression coincides with cells stained weakly with anti-Pax6 (B–D, brackets), precedes that of Lim1/2 (F–H,
arrows), and is downregulated when Lim1/2 cells migrate into the MZ (F–H, brackets). (I–P) Stage 22 chick embryos were pulsed for 1 h (I and J), 4 h (K and L),
6 h (M and N), and 12 h (O and P) with BrdU, fixed, sectioned, and stained with anti-MTGR1 (red) and anti-BrdU (green) antibodies. The boxed areas in the top
row are enlarged in the bottom row. Arrowheads in J and L point to BrdU-negative, MTGR1-positive cells. Arrowheads in N and P indicate double positive cells,
and arrows in P indicate BrdU-positive cells that had migrated into the mantle zone and turned off MTGR1 expression. Scale bar for low magnification figures:
100 Am; scale bar for enlarged pictures: 20 Am.
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MTGR1 as they make the transition between precursor cells
that express Pax6 and differentiated postmitotic neuron
marked by Lim1/2.
To further characterize the timing of MTGR1 expression
relative to cell cycle exit of neuronal precursors, chick
embryos were pulsed with BrdU for various lengths of time,
fixed, sectioned, and double-labeled with antibodies direc-
ted against MTGR1 and BrdU (Figs. 3I–P). Based on
estimates of the length of the cell cycle in chick spinal cord
(Hollyday et al., 2001; Langman et al., 1966), exposure to
BrdU for 1 h labels cells in the S-phase and the early G2-
phase while 4 h of BrdU exposure primarily labels cells inS, G2, and M phases as well as a minor population in the
early G1 phase. After 1 (Figs. 3I and J) and 4 h (Figs. 3K
and L) of BrdU labeling, cells expressing MTGR1 in the IZ
as well as a small number of MTGR1+ cells in the VZ (Figs.
3J and L, arrowheads) failed to incorporate BrdU. These
results indicate that MTGR1+ cells are likely to be in the late
G1 or more likely in the G0 phase (postmitotic). After 6 h of
BrdU labeling, BrdU staining was detected within MTGR1-
positive cells in the VZ (Figs. 3M and N, arrowheads). After
12 h, MTGR1-positive cells in the IZ became BrdU positive
(Figs. 3O and P, arrowheads). At this stage, some BrdU-
labeled cells have already migrated past the MTGR1
positive zone and entered the MZ (Figs. 3P arrows). Based
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expressed for 6–8 h starting in late G1/G0 phase as cells
migrate out of the IZ, suggesting that MTGR1 is expressed
in neural precursors after they have exited the cell cycle, and
is then further upregulated in neuronal precursors as they
move through the IZ.
Overexpression of the MTG proteins does not alter the
pattern of neuronal differentiation in chick spinal cord
Expression of the neuronal marker N-tubulin is blocked
when Xenopus embryos are injected with RNA encoding
XMTGR1 (Cao et al., 2002), suggesting that XMTGR1 acts
to inhibit neuronal differentiation. However, the results
described above indicate that in the chick spinal cord, the
MTG proteins are primarily expressed as differentiating
neurons move to the MZ, suggesting that they promote
neuronal differentiation. We therefore examined whether
misexpression of MTG proteins in the chick spinal cord also
blocks neuronal differentiation as described in Xenopus.
Embryos at Hamburger–Hamilton (HH) stage 13 were
electroporated with a DNA construct in which the chick h-
actin promoter drives expression of the myc-tagged form
of the full-length cMTGR1 (pMiwSV expression vector,
Funahashi et al., 1999). After 2 days of incubation,
electroporated embryos were harvested at stage 20–21,
sectioned, and then double labeled for both the myc tag and
a variety of neuronal markers. Even though tagged proteins
were readily detected in the nuclei of both progenitor cells
and postmitotic neurons, the pattern of both neuronal
markers (Pax2, Lim1/2, Isl 1, Prox1, TuJ1, and p27Kip1)
and progenitor markers (Pax6, Pax7, and BrdU incorpo-
ration) was unaltered on the electroporated side versus the
control side (Figs. 4G–K and data not shown). In addition,
a similar analysis was carried out with untagged protein
using co-electroporation with a tracer plasmid or staining
with the anti-MTGR1 antibody to detect transgenic cells on
the electroporated side. Again, after examination with a
panel of markers, no significant differences were detectedFig. 4. XMTGR1-MR inhibits neuronal differentiation in the chick spinal
cord: full-length molecule alone does not affect neuronal differentiation, but
rescues the dominant-negative effect. (A–F) A construct driving expression
of myc epitope-tagged XMTGR1-MR was introduced into the chick spinal
cord using in ovo electroporation at stages 12–13. Electroporated embryos
were pulsed with BrdU 1 h prior to harvest at stage 22 and sectioned.
Consecutive sections were stained with antibodies directed against NeuN
(A), Pax2 (B), Lim1/2 (C), Islet 1 (D), BrdU (E), and Prox1 (F). (a–f) The
same sections in A–F were double stained with anti-myc antibody to show
the distribution of transgenic gene expression. (G–K) Constructs driving
expression of myc-tagged full-length XMTGR1 or Luciferase was electro-
porated either alone or in combination with XMTGR1-MR construct in the
same experimental conditions as A–F. The numbers of labeled cells on the
electroporated versus the control sides were scored in at least 10 sections
from three different embryos for each group. Error bars show standard
deviation. WT, full-length XMTGR1; MR, XMTGR1-MR; resc, XMTGR1-
MR and full-length XMTGR1; luci, luciferase. (G) NeuN, (H) Pax2, (I) Lim
1/2, (J) BrdU, (K) Prox1. Scale bar: 100 Am.that would indicate alterations in neuronal differentiation
(data not shown). Identical results were obtained with
cMTG8 and cMTG16, indicating that differences between
these results and those obtained in Xenopus are not due to
differences in the MTG isoform tested. We conclude,
therefore, that misexpression of wild-type forms of MTG
proteins does not alter the pattern of neuronal differ-
entiation in the developing chick spinal cord.
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neuronal differentiation
We next used a dominant-negative approach to ask
whether inhibiting the function of the MTGR1 protein in the
developing chick spinal cord would alter neurogenesis. A
central portion of XMTGR1 including NHR2, called
XMTGR1-MR, was isolated and cloned into the pMiwSV
expression vector as a myc-tag fusion molecule. It has been
shown that oligomerization of MTG8 is obligatory for its
interaction with corepressors and for transcriptional sup-
pression through the NHR4 domain (Minucci et al., 2000;
Zhang et al., 2001). Since XMTGR1-MR contains only the
dimerization domain that allows the MTG proteins to
function as homo- and heterodimers (Davis et al., 2003;
Kitabayashi et al., 1998; Lindberg et al., 2003; Zhang et al.,
2001), we reasoned that this mutant would form nonfunc-
tional dimers with the wild-type proteins.
The MR form of MTGR1 was expressed in the
developing chick spinal cord and the formation of neurons
was examined 2 days later using the same experimental
paradigm as described above. Staining with the myc-epitope
antibody indicated that MTGR1-MR is expressed at high
levels in nuclei of approximately 50% of the spinal cord
cells following electroporation, and that these cells were
located across the mediolateral axis of the neural tube (Figs.
4a–f). In contrast to the wild-type forms of MTG proteins,
expression of MTGR1-MR produced a readily detected
phenotype when assayed using a variety of neuronal
markers (Figs. 4A–D and G–I). Expression of MTGR1-
MR, for example, reduced the number of cells expressing a
general marker of neuronal differentiation, NeuN (Figs. 4A
and G). In addition, expression of MTGR1-MR markedly
reduced the number of cells that express markers of
neuronal subtype. Thus, a reduction occurs in the number
of cells that express markers of interneurons, such as Pax2
(Figs. 4B and H) and Lim1/2 (Figs. 4C and I), as well as the
number of cells expressing a marker of motorneurons, Isl1/2
(Fig. 4D). Finally, the MZ of the neural tube was smaller on
the electroporated side, reflecting the loss of postmitotic
neurons (Fig. 4E; compare the areas of either side of the
spinal cord that are negative for BrdU staining). Thus,
XMTGR1-MR has a general inhibitory effect on the
formation of postmitotic neurons.
Several control experiments suggest that this reduction in
neuronal differentiation by the MR mutant is due to a
specific inhibition of MTG function. First, the number of
cells expressing these markers was not significantly changed
when chick embryos were electroporated using the same
amount of vector expressing luciferase (Figs. 4G–I).
Second, co-electroporation of the wild-type MTGR1 along
with the MR mutant completely rescued the reduction of
neuronal differentiation (Figs. 4G–I). Finally, the same
analysis was also carried out with MR constructs of
XMTG8 and 16, yielding the same phenotype as that
described for XMTGR1: a marked reduction in the numberof differentiating neurons (data not shown). Thus, these
results support the conclusion that the MR mutant specif-
ically inhibits neuronal differentiation by blocking at least
one function of the MTG proteins.
Alterations in cell differentiation by the MR mutant
To characterize the MR mutant phenotype further,
additional markers were used to score cells in the VZ and
IZ of embryos expressing XTGMR1-MR. Firstly, embryos
expressing XMTGR1-MR were assayed for Prox-1 whose
expression transiently marks neuronal precursors as they
exit the cell cycle within the IZ (Dyer et al., 2003; Torii et
al., 1999). Expression of XMTGR1-MR reduced the
number of cells expressing Prox-1 in a manner that was
rescued by wild-type MTGR1 (Figs. 4F and K), suggesting
that XMTGR1-MR acts in part by reducing the number of
precursors that become postmitotic. However, expression of
the MR mutant had no effect on the number of precursor
cells that can be labeled with a pulse of BrdU (Figs. 4E and
J) or on the pattern of expression of Pax6 and Pax7 (data not
shown), two transcription factors that mark different
domains of the VZ. Thus, if the MR mutant blocks the
formation of postmitotic neurons, this does not produce a
detectable increase in the number of precursors, perhaps
because of on-going rapid cell division and increase in cell
number in the VZ compared to the number of cells inhibited
from differentiation, or of compensatory mechanisms such
as programmed cell death. In addition, expression of
XMTGR1-MR did not alter the expression of Ngn2, a
proneural protein expressed in ventricular progenitors and
required for the production of postmitotic neurons (data not
shown). Thus, expression of XMTGR1-MR does not appear
to block neuronal differentiation by detectably inhibiting the
expression of critical bHLH factors.
In addition to blocking the formation of early neurons,
the MR mutant could also act by preventing the expression
of neuronal genes in the MZ. To examine this possibility,
embryos expressing either myc-tagged MR or wild-type
MTGR1 were colabeled with a myc antibody and with
various markers of neuronal differentiation. While wild-
type-expressing cells in the MZ appear normal by marker
expression (Fig. 5D and data not shown), many of the cells
expressing the MR mutant in the MZ failed to express
general neuronal markers, such as TuJ1 and NeuN (Figs. 5A
and B), or the neuronal cell type marker Pax2 (Fig. 5C).
These results indicate that XMTGR1-MR also blocks
neuronal differentiation at the point when MZ neurons
normally express genes such as TuJ1 and NeuN (see
Discussion).
Dominant-negative mutant of XMTGR1 blocks the
proneural activity of Xngn1
The results obtained above in the chick spinal cord
suggest that MTG proteins are required for progenitor cells
Fig. 5. XMTGR1-MR inhibits expression of postmitotic markers in the
chick spinal cord. A construct driving expression of myc epitope-tagged
XMTGR1-MR (A–C) or full-length XMTGR1 (D) was introduced into the
chick spinal cord and processed as described in Fig. 4. Sections were
stained with antibodies directed against myc (A–D, green labels), TuJ1 (A,
red), NeuN (B, red), and Pax 2 (C and D, red). Note that some cells
expressing dominant-negative MTGR1 fail to activate postmitotic markers
even as they migrate into the MZ (A–C, arrowheads). In contrast, most cells
expressing full-length MTGR1 coexpress Pax2 when migrated to the
appropriate domain (D, arrowheads). Boxed areas in A–D are enlarged in
the right panels. Antibody stains with neuronal markers (red), myc epitope
(green), and overlays are shown. Scale bar for low magnification figures:
100 Am; scale bar for enlarged pictures: 20 Am.
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neuronal gene expression. These observations are in contrast
to those in frog where overexpression of XMTGR1 not only
inhibits primary neurogenesis but also blocks ectopicneurogenesis in response to proneural proteins XATH3
and NeuroD. To examine this issue further, we asked
whether the wild type or mutant forms of the MTG proteins
would inhibit the ability of Xngn1 to promote neuronal
differentiation in the chick spinal cord (Fig. 6). As shown
previously, when cells in the spinal cord express high levels
of Xngn1 by electroporation, they are efficiently pushed out
of the VZ into the MZ after 2 days of electroporation
(Garcia-Dominguez et al., 2003; Lamar et al., 2001; Novitch
et al., 2001, and Fig. 6A). Coexpression of MTGR1 does
not change the distribution of cells and thus does not affect
the activity of Xngn1 in this respect, in line with the
observation that wild-type MTGR1 does not alter the pattern
of neuronal differentiation when misexpressed in the chick
spinal cord (Fig. 6B). However, expression of the MR
mutant along with Xngn1 causes a marked shift in the
distribution of electroporated cells into the VZ (Fig. 6C).
Some of the cells retained in the VZ incorporated BrdU after
1-h pulse of the drug, indicating that at least some of the
electroporated cells are still proliferating (Figs. 6D–G).
Thus, these results support the conclusion that MTGR1-MR
inhibits the ability of precursors to undergo neuronal
differentiation downstream of proneural proteins. In addi-
tion, they suggest that when the MTG protein is inhibited,
some of the neural precursors are retained in the VZ even as
they express high levels of the proneural protein Xngn1.Discussion
Here we report the isolation and expression analysis of
cDNAs encoding chick and Xenopus MTG8, MTG16, and
MTGR1, and an initial characterization of their function
during neurogenesis. Our results indicate that MTG family
members are expressed in a cascade during neuronal
differentiation, carrying out functions required for cells to
undergo terminal neuronal differentiation in the developing
spinal cord.
MTG proteins: a highly conserved protein family expressed
in postmitotic neurons
Previous studies have shown that in Xenopus embryos,
MTGR1 expression occurs transiently during primary
neurogenesis, preceding that of genes such as N-tubulin
whose expression marks definitive neurons. Indeed, this
observation was one line of evidence that MTGR1 may
function in neural precursors to prevent their differentiation
into neurons (Cao et al., 2002). However, an alternative
picture emerges when the expression of other MTG proteins
is examined during neurogenesis in both chick and
Xenopus. Both MTG8 and MTG16 are expressed in the
MZ, suggesting that they function in postmitotic neurons.
MTGR1 is expressed in cells in the IZ, but these cells do not
incorporate BrdU after 4 h of exposure and appear to be in
the process of downregulating the precursor marker Pax6
Fig. 6. A dominant-negative form but not full-length MTGR1 inhibits Xngn1 activity in the chick spinal cord. (A–C) Chick embryos were electroporated with a
myc-tagged form of Xngn1 alone (A) or along with untagged forms of full-length XMTGR1 (B) or XMTGR1-MR (C) using the same conditions as those
described in Fig. 4. Embryos were pulsed with BrdU for 1 h before harvest. The sections were double stained with anti BrdU antibody to delineate the
boundary of the VZ (outline of the BrdU positive zones are indicated by white dotted lines) and with an anti-myc antibody (red) to visualize the distribution of
Xngn1. Xngn1-expressing cells preferentially distribute in the MZ after 48 h following electroporation (A). Note that co-expression of wild-type XMTGR1
does not alter this pattern (B), whereas XMTGR1-MR shifts the distribution of cells into the VZ (C). (D) Myc+ cells on either side of the boundary were scored.
Cells located basal to the boundary were scored as postmitotic. Shown are data taken from at least six sections from three independent embryos. Error bars
show standard deviation. In E–G, the boxed area in C is enlarged. (E) Anti myc-tag stain, (F) anti-BrdU stain, and (G) overlay. Arrowheads denote myc+ cells
in the VZ that incorporated BrdU. Scale bar for A–C: 100 Am; scale bar for E–G: 20 Am.
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observations suggest that as neural precursors commit to
neuronal differentiation they activate the expression of
MTGR1+ after the final S-phase, and then switch to express
either MTG16 or MTG8 as they fully differentiate.
A requirement for the MTG proteins in neuronal
differentiation
Results obtained with the MR mutant further suggest
that MTG proteins are required by neural precursors to
undergo neuronal differentiation. Expressing the MR
mutant markedly reduces the number of cells in the
marginal zone that expresses markers of neuronal differ-
entiation as well as markers of neuronal subtype. The MR
mutant also inhibits the ability of Xngn1 to convert neural
precursors into neurons when ectopically expressed. Based
on their expression patterns and the results obtained with
the MR mutants, it seems likely that MTG family members
are required for neural precursors to undergo neuronal
differentiation during neurogenesis in the chick spinal
cord.
Our conclusions about the function of MTG proteins in
the chick spinal cord differ from that proposed for the roleof MTGR1 (ETOR) during primary neurogenesis in frog
embryos (Cao et al., 2002). One clear difference is that
overexpressing MTGR1 in frog embryos by RNA injection
blocks the formation of primary neurons as marked by the
expression of N-tubulin (Cao et al., 2002), while over-
expressing any of the MTG proteins in the chick spinal
cord has no effect on neuronal differentiation and more-
over rescues the inhibitory effects of the MR mutant.
Further work will be needed to determine whether these
different outcomes reflect the different methods used for
overexpression in chick and frog, or whether it indicates
that MTG proteins have an early role in negatively
regulating neurogenesis in the frog that does not occur in
the chick spinal cord.
Based on the results with the MR mutant, MTG
proteins could act at several levels to promote neuronal
differentiation during neurogenesis. One possibility is that
the early, low level of MTGR1 expression observed in
neural precursors is required by these cells to leave G1 and
progress into the G0 phase when the transition to a
postmitotic neuron occurs. In this scenario, blocking MTG
function would cause neural precursors to revert back into
the cell cycle and thus be retained as dividing neuro-
epithelial cells. This possibility is supported by the
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mutant continue to divide based on BrdU incorporation
(Fig. 4 and data not shown) while at the same time the MR
mutant reduces the number of cells in the IZ that express
Prox1, a homeodomain protein that has been shown to
promote cell cycle exit during neurogenesis in the retina
(Fig. 4) (Dyer et al., 2003). This possibility is also
supported by the observation that the MR mutant can
reverse at least in part the ability of Ngn1 to promote cell
cycle exit (Fig. 6). When the MTG function is inhibited in
the spinal cord by the MR mutant, therefore, at least some
neuronal precursors apparently fail to become postmitotic
even as they express high levels of Ngn1. Significantly, the
MTG proteins have also been implicated in cell cycle
control in various types of cell lines (Amann et al., 2001;
Kitabayashi et al., 1998).
Other observations suggest that members of the MTG
family are also required after cell cycle exit for neuronal
differentiation. Indeed, based on their expression patterns,
MTG8 and MTG16 members are likely to be required
late to execute some aspect of neuronal differentiation. In
line with this possibility, some MR-expressing cells are
likely to be postmitotic based on BrdU labeling and reach
the MZ but then fail to express generic and subtype-
specific neuronal markers (Fig. 5). This potential late
function of individual MTG family members needs to be
addressed further, preferably by the generation of muta-
tions that specifically disrupt the late-expressing MTG
genes.
While MTG proteins seem to be required for neuronal
differentiation in the chick spinal cord, they also appear
not to be sufficient. Overexpressing the wild-type forms of
MTG proteins does not alter gene expression associated
with neuronal differentiation nor does it change signifi-
cantly the distribution of transfected cells between a
progenitor and a neuronal cell compartment. In contrast
to a number of genes whose expression is activated by
proneural proteins, the levels of MTG proteins seem
unable to influence whether or not a progenitor cell
initiates neuronal differentiation in the chick spinal cord.
One possibility is that MTG proteins require additional
cofactors to function and that the levels of these cofactors
in the chick spinal cord are limiting relative to those of the
MTG proteins.
Potential functions for the MTG proteins during
neurogenesis
This work reveals a new aspect of the neurogenic gene
cascade initiated by proneural bHLH factors. MTG
proteins are expressed during neuronal differentiation and
may function by both promoting the transition from
precursor to neuron and the expression of neuronal genes
within differentiated cells. A number of reports using
biochemical and molecular analyses suggest the MTG
proteins function as potent transcriptional repressors(Amann et al., 2001; Davis et al., 2003; Gelmetti et al.,
1998; Lutterbach et al., 1998; Wang et al., 1998). In this
capacity, MTG proteins may act in part as corepressors
that target the repression of genes whose expression needs
to be extinguished during neuronal differentiation although
direct targets of the MTG proteins during neurogenesis are
still yet to be determined. While most studies have
emphasized the importance of transcriptional activation
during differentiation, changes in transcriptional repression
are likely to be equally relevant. This repression may be
required for inactivating gene expression required for
neural precursors to progress through the cell cycle, or
gene expression required for precursor-specific functions
such as lateral inhibition. In addition, changes in tran-
scriptional repression are also likely to be required during
neuronal differentiation as a means of repressing factors
such as REST/NRSF and SOX proteins that are known to
operate in precursors to prevent expression of neuronal
differentiation genes (Bylund et al., 2003; Chong et al.,
1995; Graham et al., 2003; Schoenherr and Anderson,
1995). Identifying MTG binding partners in the vertebrate
nervous system will be one of the crucial next steps for
understanding the targets and the mechanism of MTG
function during neurogenesis.
In addition to the function in cell cycle exit and
expression of neuronal markers, differential expression of
MTG family genes in both Xenopus and chick suggests
that they may also be involved in cell-type specification
(Fig. 2). Indeed, the murine homologs of MTG8/ETO
and MTG16/ETO2 bind to overlapping but different
members of corepressors and histone deacetylases
(Amann et al., 2001), and exhibit different subnuclear
distribution (Hoogeveen et al., 2002). By recruiting
different configuration of histone deacetylases to specific
nuclear locations, MTG proteins may generate unique
acetylation patterns of histones at each site and confer
cell-type specificity. These questions also await further
analysis preferably by loss-of-function mutations to
specifically ablate each gene.Acknowledgments
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